Cibc Private Wealth Group, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 32 shares of CRNX stock, worth $1,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$1,360% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CRNX
# of Institutions
239Shares Held
90.3MCall Options Held
59.7KPut Options Held
14.8K-
Vanguard Group Inc Valley Forge, PA9.26MShares$393 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.4MShares$272 Million1.78% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$265 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.81MShares$247 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.59MShares$238 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.29B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...